Jim joined Ankrin Therapeutics as Chairman in February 2021. He also serves as Executive Chairman for Rewind Therapeutic. Before, Jim was Executive Chairman of Black Belt Tx and CEO of Karolinska Development, a publicly listed Nordic life science investment fund. Jim is Managing Director of bioskills, which he founded in 2013, offering strategic advice and hands-on management for entrepreneurs and investors. From 2001 to 2013, he worked as a Partner at Gimv focusing on life science investments. Before that, he was working as a senior scientist at the department of Oncology at Janssen Pharmaceutica, a J&J company. Jim holds a M.Sc. degree in Chemistry and Biochemistry from the University of Antwerp (Belgium) and a Ph.D. in Molecular and Cellular Biology from the University of Maastricht (The Netherlands).